Journal article icon

Journal article

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.

Abstract:

BACKGROUND: The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) trial has recently reported. OBJECTIVE: To assess the cost effectiveness of perindopril in stable coronary heart disease in the UK. METHODS: Clinical and resource use data were taken from the EUROPA trial. Costs included drugs and hospitalisations. Health-related quality of life values were taken from published sources. A cost-effectiveness analysis is presented as a func...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/hrt.2005.086728

Authors


Journal:
Heart (British Cardiac Society) More from this journal
Volume:
93
Issue:
9
Pages:
1081-1086
Publication date:
2007-09-01
DOI:
EISSN:
1468-201X
ISSN:
1355-6037

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP